JPMorgan Chase & Co’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,225,737
| Closed | -$35.1M | – | 5107 |
|
|
2018
Q4 | $35.1M | Buy |
1,225,737
+38,487
| +3% | +$1.1M | 0.01% | 951 |
|
|
2018
Q3 | $33.1M | Buy |
1,187,250
+427,745
| +56% | +$11.9M | 0.01% | 1124 |
|
|
2018
Q2 | $21.2M | Sell |
759,505
-684,166
| -47% | -$19.1M | ﹤0.01% | 1345 |
|
|
2018
Q1 | $35.9M | Sell |
1,443,671
-370,977
| -20% | -$9.22M | 0.01% | 1035 |
|
|
2017
Q4 | $44M | Sell |
1,814,648
-56,093
| -3% | -$1.36M | 0.01% | 945 |
|
|
2017
Q3 | $51.5M | Buy |
1,870,741
+1,869,961
| +239,739% | +$51.5M | 0.01% | 838 |
|
|
2017
Q2 | $20K | Buy |
780
+110
| +16% | +$2.82K | ﹤0.01% | 3933 |
|
|
2017
Q1 | $18K | Buy |
670
+77
| +13% | +$2.07K | ﹤0.01% | 4119 |
|
|
2016
Q4 | $16K | Buy |
+593
| New | +$16K | ﹤0.01% | 4201 |
|
|
2016
Q1 | – | Sell |
-238
| Closed | -$5K | – | 4366 |
|
|
2015
Q4 | $5K | Buy |
+238
| New | +$5K | ﹤0.01% | 3762 |
|
|
2015
Q3 | – | Sell |
-23,467
| Closed | -$335K | – | 3507 |
|
|
2015
Q2 | $335K | Buy |
23,467
+6,023
| +35% | +$86K | ﹤0.01% | 3183 |
|
|
2015
Q1 | $302K | Buy |
+17,444
| New | +$302K | ﹤0.01% | 3232 |
|
|
2014
Q1 | – | Sell |
-42,636
| Closed | -$426K | – | 3684 |
|
|
2013
Q4 | $426K | Buy |
42,636
+25,000
| +142% | +$250K | ﹤0.01% | 3257 |
|
|
2013
Q3 | $232K | Sell |
17,636
-2,854
| -14% | -$37.5K | ﹤0.01% | 3620 |
|
|
2013
Q2 | $293K | Buy |
+20,490
| New | +$293K | ﹤0.01% | 3405 |
|